Highlights
- MediKane has a portfolio of plant-based natural food products with scientific and clinical evidence to improve health.
- The company targets diversified market segments including the medical, health, ingredients, animal health and white label space.
- For these five separate markets, the company uses the same technology and supply chain.
- Each market is global and growing faster than population growth.
Spending nearly a decade building the foundations to take its Australian innovations global, MediKane has witnessed its client base expand to include a diverse set of market segments.
The Australia-based company has been catering to the needs of plant-based treatments, also called Food-as-Medicine products, targeting several global chronic health conditions. The company has a portfolio of plant-based natural food products, backed by scientific and clinical evidence that they improve health.
Historically, MediKane has focused on two market areas, aiding people in managing their blood sugar levels and acute constipation caused by opioid analgesic painkillers in hospital surgeries.
The company now targets diversified market segments, covering the medical, health, ingredients, animal health and white label space.
Let us graze through the market segments wherein MediKane offers or is ready to launch its range of reliable and innovative Food-as-Medicine products.
Health
Obesity, weight gain, lifestyle changes, and food choices have dramatically increased the number of people with high blood sugar levels (BSLs). In Australia, one person develops diabetes every five minutes. There is no superpower drug for this disease, and the main emphasis is on managing lifestyle and diet choices.
In such a scenario, MediKane’s flagship product NutriKane D is well placed to tap the emerging BSL space. It has demonstrated a positive impact on high BSLs in clinical trials.
As a food product, NutriKane D has been given a green signal for claims by the Food Standards Australia New Zealand (FSANZ) regarding the management of BSLs.
MediKane’s major market areas for NutriKane D are the US, UK, and Asia.
Learn about all MediKane products
Medical
Under the medical segment, the company majorly targets private and public hospitals. Opioid Induced Constipation (OIC) is a common problem due to the prolonged use of opioid drugs, prescribed for pain management in patients after surgery.
However, OIC increases patient discomfort. It also increases the cumulative cost of treatment and hospital waiting times.
MediKane is actively pursuing major areas for using NutriKane R with a focus on the Australian and US markets. In these countries, private hospitals and facilities have an incentive for optimised cost management by improving the availability of beds.
NutriKane R, already on the market, is designed for people who want improved bowel health and regularity and looking for natural medications, plus those in hospitals or aged care facilities with constipation.
Ingredients
MediKane also supplies plant-based products to food processors through its division, MediKane Ingredients. The food processors use these ingredients to make final products. The target segments include processed meat producers, health food manufacturers and bakeries.
MediKane suggests that this global market segment of US$5.4 billion is expected to grow at a CAGR of 12.9% during 2020-2026.
MediKane has strong distribution networks in the ingredients market in Australia, Europe and the USA.
Animal health
MediKane’s products from the NutriKane range work the same way in animals as in humans. As of 2019, the global animal health market is worth US$637 million and is growing at an annual rate of 6.4 %, as per the company. The market growth is mainly backed by socioeconomic factors and the humanisation of pets.
MediKane has created a joint venture to tap into this segment. The venture is called PetKane and several of the key personnel involved have already been conducting scientific tests for the past five years on dogs, cats, and horses, with NutriKane proving its efficiency. PetKane is developing relationships with a global network of veterinarians and other animal lovers.
PetKane is now selling, under the brand name Chica, with animal products in powder form.
White Label
Owing to the quality of ingredients offered, MediKane has established a growing White Label business. The company believes its new and unique product offerings have the potential for outstanding growth.
The company expects the human nutrition market to grow at a robust pace over the coming years due to increasing consumer awareness about healthy living and eating benefits.
Backed by a global presence and innovative set of product offerings, MediKane is committed to becoming a major provider of safe plant-based ‘Food-as-Medicine’ products for the treatment of specific acute and chronic health problems.